V
Valdilea G. Veloso
Researcher at Oswaldo Cruz Foundation
Publications - 335
Citations - 13392
Valdilea G. Veloso is an academic researcher from Oswaldo Cruz Foundation. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 40, co-authored 272 publications receiving 10684 citations. Previous affiliations of Valdilea G. Veloso include National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
Robert M. Grant,Javier R. Lama,Peter L. Anderson,Vanessa McMahan,Albert Y. Liu,Lorena Vargas,Pedro Goicochea,Martin Casapia,Juan Vicente Guanira-Carranza,Maria Esther Ramirez-Cardich,Orlando Montoya-Herrera,Telmo Fernandez,Valdilea G. Veloso,Susan Buchbinder,Suwat Chariyalertsak,Mauro Schechter,Linda-Gail Bekker,Kenneth H. Mayer,Esper G. Kallas,K. Rivet Amico,Kathleen Mulligan,Lane R. Bushman,Robert J. Hance,Carmela Ganoza,Patricia Defechereux,Brian S. Postle,Furong Wang,J. Jeff McConnell,Jia-Hua Zheng,Jeanny Lee,James F. Rooney,Howard S. Jaffe,Ana Martinez,David N. Burns,David V. Glidden +34 more
TL;DR: Oral FTC-TDF provided protection against the acquisition of HIV infection among the subjects and Detectable blood levels strongly correlated with the prophylactic effect.
Journal ArticleDOI
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study
Robert M. Grant,Robert M. Grant,Robert M. Grant,Peter L. Anderson,Vanessa McMahan,Albert Y. Liu,K. Rivet Amico,Megha Mehrotra,Sybil G. Hosek,Carlos Mosquera,Martin Casapia,Orlando Montoya,Susan Buchbinder,Valdilea G. Veloso,Kenneth H. Mayer,Suwat Chariyalertsak,Linda-Gail Bekker,Esper G. Kallas,Mauro Schechter,Juan V. Guanira,Lane R. Bushman,David N. Burns,James F. Rooney,David V. Glidden +23 more
TL;DR: The effect of PrEP is increased by greater uptake and adherence during periods of higher risk, and drug concentrations in dried blood spots are strongly correlated with protective benefit.
Journal ArticleDOI
Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.
Peter L. Anderson,David V. Glidden,Albert Y. Liu,Susan Buchbinder,Javier R. Lama,Juan V. Guanira,Vanessa McMahan,Lane R. Bushman,Martin Casapia,Orlando Montoya-Herrera,Valdilea G. Veloso,Kenneth H. Mayer,Kenneth H. Mayer,Suwat Chariyalertsak,Mauro Schechter,Linda-Gail Bekker,Esper G. Kallas,Robert M. Grant +17 more
TL;DR: PrEP using oral FTC-TDF tablets is a robust intervention for preventing HIV acquisition among men who have sex with men, and specific drug concentrations associated with protection from HIV-1 acquisition in the iPrEx trial are estimated.
Journal ArticleDOI
Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
Diane V. Havlir,Michelle A. Kendall,Prudence Ive,Johnstone Kumwenda,Susan Swindells,Sarojini S. Qasba,Anne F Luetkemeyer,Evelyn Hogg,James F. Rooney,Xingye Wu,Mina C. Hosseinipour,Umesh G. Lalloo,Valdilea G. Veloso,Fatuma Some,N. Kumarasamy,Nesri Padayatchi,Breno Santos,Stewart E Reid,James Hakim,Lerato Mohapi,Peter Mugyenyi,Jorge Sanchez,Javier R. Lama,Jean W. Pape,Alejandro Sanchez,Aida Asmelash,Evans Moko,Fred Sawe,Janet Andersen,Ian Sanne +29 more
TL;DR: In persons with CD4+ T-cell counts of less than 50 per cubic millimeter, earlier ART was associated with a lower rate of new AIDS-defining illnesses and death, as compared with later ART.
Journal ArticleDOI
Three Postpartum Antiretroviral Regimens to Prevent Intrapartum HIV Infection
Karin Nielsen-Saines,D. Heather Watts,Valdilea G. Veloso,Yvonne J. Bryson,Esau Joao,José Henrique Pilotto,Glenda E. Gray,Gerhard Theron,Breno Santos,Rosana Fonseca,Regis Kreitchmann,Jorge Pinto,Marisa Márcia Mussi-Pinhata,Mariana Ceriotto,Daisy Maria Machado,James Bethel,Marisa G. Morgado,Ruth Dickover,Margaret Camarca,Mark Mirochnick,George K. Siberry,Beatriz Grinsztejn,Ronaldo I. Moreira,Francisco Inácio Bastos,Jiahong Xu,Jack Moye,Lynne M. Mofenson +26 more
TL;DR: In neonates whose mothers did not receive antenatal antiretroviral therapy during pregnancy, prophylaxis with a two- or three-drug ART regimen is superior to zidovudine alone for the prevention of intrapartum HIV transmission; the two-drug regimen has less toxicity than the three- drug regimen.